JAMP Pharma Corp., a Quebec pharmaceutical maker, is recalling one lot of JAMP-Pregabalin ache drugs as a result of bottles labelled to include 50-milligram capsules could include 150-milligram capsules as an alternative.
Well being Canada introduced the recall in an uncommon Saturday night assertion.
The announcement mentioned the corporate’s mix-up may result in sufferers taking a a lot bigger dose of the painkiller than prescribed, probably leading to an overdose that might “pose severe, probably deadly well being dangers.”
JAMP-Pregabalin is an grownup prescription drug. It’s used to deal with ache brought on by nerve harm resulting from diabetes, shingles or spinal twine damage. Additionally it is used to deal with ache related to fibromyalgia, Well being Canada mentioned.
The recall impacts one lot of the 50-mg capsules bearing lot quantity 2305012747, which carries a 2026-08 expiry date, Well being Canada mentioned.
Well being Canada confused that taking an excessive amount of pregabalin or all of the sudden rising the dose may probably result in sufferers overdosing, which could be life-threatening.
Get weekly well being information
Obtain the most recent medical information and well being data delivered to you each Sunday.
The federal government urged each abnormal sufferers and well being professionals, similar to pharmacists, to verify the contents of their JAMP-Pregabalin 50-mg bottles and see in the event that they include 150-mg capsules.
A 150-mg capsule of JAMP-Pregabalin ache drugs.
Well being Canada
The company warned that signs of pregabalin overdose could embody sudden temper modifications, sleepiness, confusion, despair, agitation, restlessness and seizures. It urged anybody taking the remedy experiencing such signs to hunt quick medical consideration.
It additionally said that taking an excessive amount of pregabalin whereas taking different medication that act on the central nervous system, together with opioids, “has been related to coronary heart electrical issues, seizures and dying.”
Sufferers shouldn’t abruptly cease taking pregabalin, as this may occasionally lead to withdrawal signs together with insomnia, nausea, headache, anxiousness, extreme sweating, diarrhea and convulsions, it mentioned.
“This recall has been initiated on Friday, proactively and voluntarily, following discussions with Well being Canada. Please notice that to our information, no affected person has been impacted by this example. We took quick motion primarily based on a standard alignment with Well being Canada to make sure affected person security,” JAMP Pharma spokesperson Alexandra Lewicki mentioned in an e mail to International Information.
It’s unclear what number of bottles of drugs and what number of capsules have been included within the lot recalled.
Well being Canada mentioned it’s monitoring JAMP Pharma’s recall and investigation of the mix-up, “together with its implementation of corrective and preventive actions to forestall this problem from reoccurring.”
Sufferers are being suggested to verify their remedy bottles or bundle very fastidiously.
“In case your prescription is for 50 mg capsules and the bottle incorporates any 150 mg capsules, or if you’re not sure, return it to your pharmacy instantly,” Well being Canada mentioned. “If you’re unable to return your capsules to the pharmacy immediately, speak to your pharmacist or physician for additional steerage.”
© 2025 International Information, a division of Corus Leisure Inc.
Source link